Test Price
3,200 AED✅ Home Collection Available
Pediatric Acute Lymphoblastic Leukemia Genetic Panel (Karyotyping + MLPA + FISH) in UAE | 3200 AED | DHA Licensed
Executive Summary & Core Metrics
A definitive, integrated cytogenomic assay for pediatric acute lymphoblastic leukemia, combining conventional G-banded karyotyping, high-resolution MLPA deletion/duplication screening, and targeted FISH probes. Processed in our ISO 9001:2015 accredited facility with 7–10 day turnaround. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM across the UAE, with direct billing insurance verification via WhatsApp at +971 54 548 8731. Results include expert telephonic clinical guidance by a DHA-licensed Consultant Medical Geneticist.
Test Overview & Methodology
This panel detects chromosomal abnormalities including hyperdiploidy, hypodiploidy, and translocations, as well as submicroscopic deletions and duplications critical for ALL risk stratification and therapy selection. The integrated approach eliminates diagnostic gaps inherent to standalone karyotyping.
| Feature | Our Test: Precision / Method / Speed | Standard Karyotyping Only |
|---|---|---|
| Precision | 550-band karyotyping + exon-level MLPA + locus-specific FISH validation | Limited to 400–500 bands, submicroscopic alterations missed |
| Method | G-banding, SALSA MLPA Probemix, Vysis/Abbott FISH probes | G-banding only |
| Speed | 7–10 working days (concurrent analyses) | 14–21 days |
Physician Insight & Safety Protocols
"As a DHA-licensed Consultant Medical Geneticist, I emphasize that this panel must be interpreted alongside clinical presentation and flow cytometry. A normal karyotype or negative MLPA does not exclude ALL—low-level clonal populations may be missed, and cryptic fusions require FISH. Never discontinue prescribed medications, including corticosteroids or chemotherapy, without direct consultation with your treating oncologist." — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory: Medication Continuation
Do not discontinue prescribed medication without consulting your doctor. Maintain all current therapies unless explicitly instructed otherwise by your treating physician.
Exclusion Criteria & Emergency Red Flags
- Hemodynamic instability or active severe infection – postpone elective genetic testing until stabilized.
- Severe thrombocytopenia below 20,000 per microliter without platelet support.
- If the child develops fever above 38.5 degrees Celsius, new bleeding, or severe bone pain, seek immediate emergency care; do not wait for test results.
Patient FAQ & Clinical Guidance
1. When is this test indicated?
Our pediatric ALL panel stratifies patients into standard, high-risk, and very high-risk groups for tailored treatment decisions. It is performed at initial diagnosis of suspected or confirmed acute lymphoblastic leukemia in children, defining genetic subtypes such as ETV6-RUNX1, BCR-ABL1, KMT2A rearrangements, and ploidy status.
2. Does the test require fasting or special preparation?
No fasting or medication interruption is required; routine hydration and normal meals can continue before sample collection. The child can eat and drink as usual. For bone marrow aspirate collection, light sedation or anesthesia is administered by a specialist in a hospital setting.
3. How long will it take to receive results, and how will I get them?
Standard turnaround time is 7 to 10 working days; secure digital reports and physician-led interpretation calls are provided promptly. Results are encrypted and emailed, with an option for a teleconsultation with our DHA-licensed clinical team to explain the findings.
UAE Regulatory & Data Privacy Adherence
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Genetic testing in minors requires explicit parental consent and a valid clinical indication. All laboratory processes are ISO 9001:2015 certified.
Clinical & Logistical Metadata
| Test Name | Pediatric Acute Lymphoblastic Leukemia Genetic Panel (Karyotyping + MLPA + FISH) |
| Price (AED) | 3,200 AED |
| Turnaround Time | 7–10 working days |
| Sample Type / Matrix | 2 mL peripheral blood in sodium heparin tube (VIP Mobile Phlebotomy & Cold-Chain Home Collection available); OR 1–2 mL bone marrow aspirate (Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety) |
| Methodology Used | G-banded karyotyping (550-band resolution), SALSA MLPA Probemix for deletion/duplication analysis, and locus-specific Vysis/Abbott FISH probes |
| ICD-10-CM Code | C91.0 |
| LOINC Code | 80562-5 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab Branding: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians